Survival analysis of drug effectiveness of remdesivir and dexamethasone for confirmed COVID-19 patients using Japanese medical claim data
Remdesivir and dexamethasone did not demonstrate a clear survival benefit among hospitalized COVID-19 patients requiring oxygen administration or respiratory ventilation.
Authors
- Kiyosu Taniguchi (ORCID: https://orcid.org/0000-0003-4584-6168)
- Shingo Mitsushima (ORCID: https://orcid.org/0000-0002-5827-5475)
- Hiromasa Horiguchi (ORCID: https://orcid.org/0000-0002-4921-7652)
Institutions
- Mie University (JP)
- National Hospital Organization (JP)
- National Mie Hospital (JP)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1016/j.ijid.2025.108268
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00